COURSE DIRECTOR
Rebecca King, M.D.

DESCRIPTION
This series will be offered quarterly on Tuesdays, Noon - 1 pm.  
The Hematopathology Grand Rounds venue utilizes experts in the field of Hematopathology who are at the forefront of cutting edge diagnostic, ancillary and molecular techniques.  Presentations by a visiting professor focus on the advancement of the field of Hematopathology through diagnostic, prognostic and therapeutic applications and the direct impact they have on quality patient care. This will enable exposure of our faculty, trainees, and allied health staff to a variety of perspectives on diagnostic and research-based hematopathology. 

TARGET AUDIENCE
The target audience includes M.D. (hematopathologists), Ph.D. (cytogeneticists), pathology residents/fellows, allied health staff (physician extenders, genetic counselors, technologists) 

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Develop a foundation of diagnostic Hematopathology concepts through molecular biology topics. 
• Utilize learned molecular biology and augmented intelligence concepts to diagnostic Hematopathology.
• Apply diagnostic Hematopathology concepts to ensure proper lymphoma and leukemia diagnosis and classification.
• Review tissue utilization techniques to optimize patient care.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CREDIT STATEMENT(S)
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies: 
Linda Baughn, Ph.D. - Other Consulting Activities - Genentech (General Consulting); Board of Directors - Cancer Genomics Consortium.

All relevant financial relationships have been mitigated. 

No relevant financial relationship(s) with ineligible companies:
Rebecca King, M.D
Jennifer Embers, MLS (ASCP) (Coordinator)
Lisa Hartzheim, MT (ASCP) (Coordinator)

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

QUESTIONS?
Contact Jenn Embers or Lisa Hartzheim